When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VBLT - VBL Therapeutics late-stage study of lead drug in ovarian cancer to continue
Vascular Biogenics Ltd.
The independent Data Safety Monitoring Committee (DSMC) has completed second interim analysis for VBL Therapeutics' (VBLT-5.0%) ofranergene obadenovec (VB-111) Phase 3 ((OVAL)) trial in platinum-resistant ovarian cancer and recommended that the study continue unmodified.
More news on: Vascular Biogenics Ltd., Healthcare stocks news, Stocks on the move,